The Patent Finder

Terms ending in 2036

DCB-USA LLC

Every in-force patent on DCB-USA LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,174,322Short Interfering RNA for Treating Cancer
In force
 · High confidence
National Cheng Kung UniversityIn forceHigh confidence
US 10,980,853Process for Preparing a Crassocephalum Crepidioides Extract, Extract Prepared Thereby and Use of the Extract
In force
 · High confidence
Development Center for BiotechnologyIn forceHigh confidence
US 10,633,453Antibody Locker for the Inactivation of Protein Drug
In force
 · High confidence
DCB-USA LLC and Kaohsiung Medical UniversityIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by DCB-USA LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited